Cite
HARVARD Citation
Tran, H. et al. (2021). Clinical Outcomes in Non–Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling. JCO precision oncology. p. . [Online].